Report overview
The 2 components of early detection of cancer are early diagnosis (or downstaging) and screening. Early diagnosis focuses on detecting symptomatic patients as early as possible, while screening consists of testing healthy individuals to identify those having cancers before any symptoms appear.
This report aims to provide a comprehensive presentation of the global market for Cancer Early Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Early Detection. This report contains market size and forecasts of Cancer Early Detection in global, including the following market information:
Global Cancer Early Detection Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Cancer Early Detection Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Cancer Early Detection companies in 2022 (%)
The global Cancer Early Detection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Colorectal Cancer Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Early Detection include Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, Oncognostic and Epigenomics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Early Detection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Early Detection Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Early Detection Market Segment Percentages, by Type, 2022 (%)
Colorectal Cancer
Liver Cancer
Lung Cancer
Other
Global Cancer Early Detection Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Early Detection Market Segment Percentages, by Application, 2022 (%)
Hospital
Medical Center
Other
Global Cancer Early Detection Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Early Detection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Early Detection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cancer Early Detection revenues share in global market, 2022 (%)
Key companies Cancer Early Detection sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Cancer Early Detection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Exact Sciences
Grail
Genetron Health
New Horizon Health
Burning Rock
Berry Oncology
Shanghai Kunyuan Biotechnology
Oncognostic
Epigenomics
Abbott
Qiagen
iStat Biomedical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Early Detection, market overview.
Chapter 2: Global Cancer Early Detection market size in revenue and volume.
Chapter 3: Detailed analysis of Cancer Early Detection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Early Detection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cancer Early Detection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
